Multiple Sclerosis Therapy: Human Pluripotent Stem Cell-derived Neural Progenitor Cells.

Bernard, Claude (Primary Chief Investigator (PCI))
Laslett, Andrew (Chief Investigator (CI))
O'Brien, Carmel (Chief Investigator (CI))

MONASH UNIVERSITY

Project: Research

Status	Finished
Effective start/end date	1/07/12 → 30/12/16

Funding

National Health & Medical Research Council (NHMRC): AUD1,448,887.50
National Health & Medical Research Council (NHMRC)
National Health & Medical Research Council (NHMRC): AUD295,777.50

Related content

Research Output

CNS accumulation of regulatory B cells is VLA-4-dependent

Research output: Contribution to journal › Article › Research › peer-review

Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen

Research output: Contribution to journal › Article › Research › peer-review

Graphene functionalized scaffolds reduce the inflammatory response and supports endogenous neuroblast migration when implanted in the Adult Brain

Research output: Contribution to journal › Article › Research › peer-review

APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation

Research output: Contribution to journal › Article › Research › peer-review

In vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression

Research output: Contribution to journal › Article › Research › peer-review

Inactive GSK3b is disturbed in the spinal cord during experimental autoimmune encephalomyelitis, but rescued by stem cell therapy

Research output: Contribution to journal › Article › Research › peer-review

Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis

Research output: Contribution to journal › Article › Research › peer-review